These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26695686)
1. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site. Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686 [TBL] [Abstract][Full Text] [Related]
2. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk. Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121 [TBL] [Abstract][Full Text] [Related]
3. A functional Variant (Rs35592567) in TP63 at 3q28 is Associated with Gastric Cancer Risk via Modifying its Regulation by MicroRNA-140. Lu C; Yang Y; Ma S Cell Physiol Biochem; 2018; 47(1):235-244. PubMed ID: 29763931 [TBL] [Abstract][Full Text] [Related]
4. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Stern MC; Van Den Berg D; Yuan JM; Conti DV; Gago-Dominguez M; Pike MC; Xiang YB; Gao YT; Cortessis VK Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3057-61. PubMed ID: 19843673 [TBL] [Abstract][Full Text] [Related]
5. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Lehmann ML; Selinski S; Blaszkewicz M; Orlich M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Beg AE; Aslam M; Bánfi G; Romics I; Ickstadt K; Schwender H; Winterpacht A; Hengstler JG; Golka K Arch Toxicol; 2010 Dec; 84(12):967-78. PubMed ID: 21063684 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants in miRNAs predict bladder cancer risk and recurrence. Wang M; Chu H; Li P; Yuan L; Fu G; Ma L; Shi D; Zhong D; Tong N; Qin C; Yin C; Zhang Z Cancer Res; 2012 Dec; 72(23):6173-82. PubMed ID: 22846912 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63. Martínez-Campelo L; Blanco-Verea A; López-Fernández T; Martínez-Monzonís A; Buño A; Mazón P; Zamora P; Norton N; Reddy JS; Velasco-Ruiz A; González-Neira A; Vulsteke C; Alonso-Gordoa T; Cruz R; Diz-de Almeida S; Carracedo A; González-Juanatey JR; López-Sendón J; Brion M; Sci Rep; 2024 Aug; 14(1):18413. PubMed ID: 39117733 [TBL] [Abstract][Full Text] [Related]
9. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians. Singh V; Jaiswal PK; Mittal RD Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484 [TBL] [Abstract][Full Text] [Related]
10. Common predisposition alleles for moderately common cancers: bladder cancer. Kiltie AE Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630 [TBL] [Abstract][Full Text] [Related]
11. Variation in TP63 is associated with lung adenocarcinoma in the UK population. Wang Y; Broderick P; Matakidou A; Vijayakrishnan J; Eisen T; Houlston RS Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1453-62. PubMed ID: 21610222 [TBL] [Abstract][Full Text] [Related]
12. Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia. Hosgood HD; Wang WC; Hong YC; Wang JC; Chen K; Chang IS; Chen CJ; Lu D; Yin Z; Wu C; Zheng W; Qian B; Park JY; Kim YH; Chatterjee N; Chen Y; Chang GC; Hsiao CF; Yeager M; Tsai YH; Wei H; Kim YT; Wu W; Zhao Z; Chow WH; Zhu X; Lo YL; Sung SW; Chen KY; Yuenger J; Kim JH; Huang L; Chen YH; Gao YT; Kim JH; Huang MS; Jung TH; Caporaso N; Zhao X; Huan Z; Yu D; Kim CH; Su WC; Shu XO; Kim IS; Bassig B; Chen YM; Cha SI; Tan W; Chen H; Yang TY; Sung JS; Wang CL; Li X; Park KH; Yu CJ; Ryu JS; Xiang Y; Hutchinson A; Kim JS; Cai Q; Landi MT; Lee KM; Hung JY; Park JY; Tucker M; Lin CC; Ren Y; Perng RP; Chen CY; Jin L; Chen KC; Li YJ; Chiu YF; Tsai FY; Yang PC; Fraumeni JF; Seow A; Lin D; Zhou B; Chanock S; Hsiung CA; Rothman N; Lan Q Hum Genet; 2012 Jul; 131(7):1197-203. PubMed ID: 22367405 [TBL] [Abstract][Full Text] [Related]
13. Common genetic variants on 3q28 contribute to non-small cell lung cancer susceptibility: evidence from 10 case-control studies. Jin YX; Jiang GN; Zheng H; Duan L; Ding JA Mol Genet Genomics; 2015 Apr; 290(2):573-84. PubMed ID: 25344291 [TBL] [Abstract][Full Text] [Related]
14. Association between MYC rs9642880[T] allele and bladder cancer risk: a meta-analysis. Zhao Y; Qi JG; Yang N; Lin YL; Liang J; Zhu X Genet Mol Res; 2015 Nov; 14(4):14745-51. PubMed ID: 26600535 [TBL] [Abstract][Full Text] [Related]
15. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Rothman N; Garcia-Closas M; Chatterjee N; Malats N; Wu X; Figueroa JD; Real FX; Van Den Berg D; Matullo G; Baris D; Thun M; Kiemeney LA; Vineis P; De Vivo I; Albanes D; Purdue MP; Rafnar T; Hildebrandt MA; Kiltie AE; Cussenot O; Golka K; Kumar R; Taylor JA; Mayordomo JI; Jacobs KB; Kogevinas M; Hutchinson A; Wang Z; Fu YP; Prokunina-Olsson L; Burdett L; Yeager M; Wheeler W; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Andriole G; Grubb R; Black A; Jacobs EJ; Diver WR; Gapstur SM; Weinstein SJ; Virtamo J; Cortessis VK; Gago-Dominguez M; Pike MC; Stern MC; Yuan JM; Hunter DJ; McGrath M; Dinney CP; Czerniak B; Chen M; Yang H; Vermeulen SH; Aben KK; Witjes JA; Makkinje RR; Sulem P; Besenbacher S; Stefansson K; Riboli E; Brennan P; Panico S; Navarro C; Allen NE; Bueno-de-Mesquita HB; Trichopoulos D; Caporaso N; Landi MT; Canzian F; Ljungberg B; Tjonneland A; Clavel-Chapelon F; Bishop DT; Teo MT; Knowles MA; Guarrera S; Polidoro S; Ricceri F; Sacerdote C; Allione A; Cancel-Tassin G; Selinski S; Hengstler JG; Dietrich H; Fletcher T; Rudnai P; Gurzau E; Koppova K; Bolick SC; Godfrey A; Xu Z; Sanz-Velez JI; D García-Prats M; Sanchez M; Valdivia G; Porru S; Benhamou S; Hoover RN; Fraumeni JF; Silverman DT; Chanock SJ Nat Genet; 2010 Nov; 42(11):978-84. PubMed ID: 20972438 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs". Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501 [TBL] [Abstract][Full Text] [Related]
17. Novel mutations in the TP63 gene are potentially associated with Müllerian duct anomalies. Wang X; Zhang X; Liu S; Li G; Cui L; Qin Y; Chen ZJ Hum Reprod; 2016 Dec; 31(12):2865-2871. PubMed ID: 27798044 [TBL] [Abstract][Full Text] [Related]
18. Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. Mittal RD; Gangwar R; George GP; Mittal T; Kapoor R DNA Cell Biol; 2011 Jun; 30(6):401-6. PubMed ID: 21345130 [TBL] [Abstract][Full Text] [Related]
19. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427 [TBL] [Abstract][Full Text] [Related]
20. A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer. Wu J; Huang Q; Meng D; Huang M; Li C; Qin T PLoS One; 2016; 11(7):e0159115. PubMed ID: 27438131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]